Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei. - Test2 - elhamkhani - TriplyDB

Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei.

Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei.

http://www.wikidata.org/entity/Q35345951

about

Animal models for Francisella tularensis and Burkholderia species: scientific and regulatory gaps toward approval of antibiotics under the FDA Animal Rule Insights into -Lactamases from Burkholderia Species, Two Phylogenetically Related yet Distinct Resistance Determinants Construction of a broad-host-range Tn7-based vector for single-copy P(BAD)-controlled gene expression in gram-negative bacteria.φX216, a P2-like bacteriophage with broad Burkholderia pseudomallei and B. mallei strain infectivity.Within-Host Evolution of Burkholderia pseudomallei during Chronic Infection of Seven Australasian Cystic Fibrosis Patients.An avirulent Burkholderia pseudomallei ∆purM strain with atypical type B LPS: expansion of the toolkit for biosafe studies of melioidosis.Rapid Burkholderia pseudomallei identification and antibiotic resistance determination by bacteriophage amplification and MALDI-TOF MS.Evolution of Burkholderia pseudomallei in recurrent melioidosis.Burkholderia pseudomallei known siderophores and hemin uptake are dispensable for lethal murine melioidosis Treatment and prophylaxis of melioidosis Burkholderia pseudomallei sequencing identifies genomic clades with distinct recombination, accessory, and epigenetic profiles.T Cell Immunity to the Alkyl Hydroperoxide Reductase of Burkholderia pseudomallei: A Correlate of Disease Outcome in Acute Melioidosis.Rapid Antimicrobial Susceptibility Testing of Bacillus anthracis, Yersinia pestis, and Burkholderia pseudomallei by Use of Laser Light Scattering Technology Transient In Vivo Resistance Mechanisms of Burkholderia pseudomallei to Ceftazidime and Molecular Markers for Monitoring Treatment Response.Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei Infection, 2010 Exposing a β-Lactamase "Twist": the Mechanistic Basis for the High Level of Ceftazidime Resistance in the C69F Variant of the Burkholderia pseudomallei PenI β-Lactamase.A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes.Membrane-Bound PenA β-Lactamase of Burkholderia pseudomallei In Vitro Susceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014).Bacterial gene loss as a mechanism for gain of antimicrobial resistance.Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infection Less is more: Burkholderia pseudomallei and chronic melioidosis Secondary metabolites from Bacillus amyloliquefaciens isolated from soil can kill Burkholderia pseudomallei Emergence of antibiotic-resistant extremophiles (AREs).Ceftazidime for respiratory infections.Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis.Melioidosis and the kidney.Melioidosis: molecular aspects of pathogenesis.One ring to rule them all: Current trends in combating bacterial resistance to the β-lactams Susceptibility of Clinical Isolates of Burkholderia pseudomallei to a Lipid A Biosynthesis Inhibitor.Loss of Methyltransferase Function and Increased Efflux Activity Leads to Doxycycline Resistance in Burkholderia pseudomallei.Chitin Oligosaccharide (COS) Reduces Antibiotics Dose and Prevents Antibiotics-Caused Side Effects in Adolescent Idiopathic Scoliosis (AIS) Patients with Spinal Fusion Surgery.Antibiotic resistance in Burkholderia species Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection.Antibiotic Resistance Markers in Burkholderia pseudomallei Strain Bp1651 Identified by Genome Sequence Analysis.Comparative analysis of the Burkholderia cenocepacia K56-2 essential genome reveals cell envelope functions that are uniquely required for survival in species of the genus Burkholderia.Diversity and regulation of intrinsic β-lactamases from non-fermenting and other Gram-negative opportunistic pathogens.Targeting the nonmevalonate pathway in Burkholderia cenocepacia increases susceptibility to certain β-lactam antibiotics.Transcriptional and post-transcriptional regulation of PenA β-lactamase in acquired Burkholderia pseudomallei β-lactam resistance.Why is the response rate slow in ceftazidime therapy for melioidosis?

P2860

Q26859041-C29CC2D4-CCCE-49C0-A808-F81C4CB176D4 Q27678056-4E9584B0-6BC7-4A94-B0C5-C4E16B4E3D82 Q30418432-3DFFB1DE-6A37-457E-B51C-18988CD60B35 Q30458468-75BC1FFD-D79A-4CCF-9702-359A9D50B6E7 Q33555304-4436C1DB-FAE3-4984-920A-F2344B93727B Q33771536-AECF25FA-E1C1-43EA-B191-336C9BABAC6B Q33877994-BBF438EE-B3CB-437C-973A-26FCDC2E9914 Q34277284-88A67565-4F1B-4FE4-BDC9-CB9F5846F1DA Q34321739-DACB7AC2-0337-495B-A5C7-D7C2D90C85FE Q34538191-BE5CFAC3-42F2-48F4-9363-7319148240C6 Q35049384-696A4E7E-BD68-4463-8D1F-A7B25129C0AB Q35560710-688D8790-61B4-4661-B351-338034612CE9 Q35960287-E5BB1F17-DC70-41F0-8080-57B0E21AF429 Q36247396-2F70621E-1E11-48F0-85C3-015638F670B6 Q36570592-F178DF7C-4FCF-40F4-911A-FED481395652 Q36571985-24F0FFC5-19A1-4F0E-BD47-BEEAD64AD0C0 Q36630989-7070B0C2-DC6D-453E-8238-6FD788122445 Q36644825-0D98FAA2-937D-44DE-B8C6-57BF60CFAF6F Q36888062-1114ED45-2B05-48B8-BE1B-F82F26C1A268 Q37015333-E6602DDF-1467-4DB7-ADCC-52C95D619271 Q37074494-438065FA-75BE-4900-AB76-8F7557BD6336 Q37194316-6D3D2371-DEDF-493B-8D3E-245A391A0C4D Q37553152-BD0A6EE2-AD59-43F3-A1CA-0195B2260601 Q38036072-4CCD999F-6EA5-48B8-9609-B6C18DDBFD7B Q38040144-B5CA7707-9A41-4431-A0DA-8713F5EE62C0 Q38066577-3F771524-4510-437A-8E84-6F7EF4D40F21 Q38070912-1B91DCD0-9E62-415A-9B0B-05E15191BA2C Q38259874-D08BDDA4-4B77-4F3A-82B1-98490ADFA60E Q38712471-171C6AD1-7487-4ECA-B2CD-FBFD94D899C8 Q39446204-A41BF865-A694-4E8B-9B30-4FC4CC6D46C8 Q39582866-024BED23-713F-4EB4-B49D-FAB9144AAD83 Q40281317-37BA5506-A70F-4128-8EEB-4C4D561D741E Q40542863-D7CE69E4-9310-4A36-B6D0-7A0CC7EB8892 Q41874947-03BDF2DF-50A3-4879-A4A1-D70FB95D1C85 Q44423713-15FC6062-0D95-45D4-BE68-1B4316FC00D6 Q46247493-3F5F1A47-FD73-46CB-BC38-95F3E5DC1892 Q46286684-B292A2F4-D4D0-46C5-B730-8045F81DCD30 Q49025273-C726D044-08D2-44E0-B02E-B826963495DF Q55715517-EA80BB2D-CE57-4FB6-A29B-9BD05DDB8FE8 Q57031012-3B552CE0-4159-41FF-B1E2-09B1C6A9AB93

P2860

Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei.

http://www.wikidata.org/entity/Q35345951

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Antimicrobial resistance to ce ...... in Burkholderia pseudomallei.

@ast

Antimicrobial resistance to ce ...... in Burkholderia pseudomallei.

@en

type

label

Antimicrobial resistance to ce ...... in Burkholderia pseudomallei.

@ast

Antimicrobial resistance to ce ...... in Burkholderia pseudomallei.

@en

prefLabel

Antimicrobial resistance to ce ...... in Burkholderia pseudomallei.

@ast

Antimicrobial resistance to ce ...... in Burkholderia pseudomallei.

@en

P1433

Q35345951-5376F01C-39F2-47CA-BAA2-370582215708

P1476

Q35345951-669E2767-82C7-4D52-9FB6-6C38526EBFD7

P2093

Q35345951-1C2CD801-302D-4773-AD5E-36891B799010

Q35345951-4EB3663F-06E3-4387-8EF4-646EC905CFEE

Q35345951-56E6C067-688D-460B-9493-CB72676670F6

Q35345951-5B1A4199-E8F1-48DE-9CAF-ECE35E3A48CC

Q35345951-6B140736-EC84-444D-A5B9-E19540683EE3

Q35345951-A1C5E695-E79B-4AFA-9BC1-761F05854EF1

Q35345951-A4FABB58-1462-4F93-8D10-D932217DDA52

Q35345951-A5BB5C06-F88D-40C1-9C0C-FCF12BFED24C

Q35345951-ABD430B2-AB6C-429F-812A-9274007F54E0

Q35345951-F2940B68-42C6-45D4-872E-F339E8F3A443

P2860

Q35345951-0B050407-8D5B-4409-9723-9D1EA94066CA

Q35345951-19991BE0-BEDF-4561-869C-DFAFCC031F97

Q35345951-1DC20634-8E6B-4735-B084-292D29D59085

Q35345951-218D7F84-9745-4FC7-A8EB-C3ADE6F360C9

Q35345951-29BC82D7-1DB6-43EA-995E-B36BA98863FB

Q35345951-3D25DD02-8CF1-4E8B-9C72-90B51E9715F2

Q35345951-48DF4CBE-E531-4978-A60E-1AD98D7A1566

Q35345951-72F90F7B-5967-48EC-8D8A-1BA852DE6C97

Q35345951-7338737E-76B4-4649-87C6-B2045AC68B2B

Q35345951-79B7025C-05AF-4279-A411-83A230B6B36D

P304

Q35345951-DF41CCED-24A6-442B-BD7A-CA18C4445F98

P31

Q35345951-0336EA24-2A32-4FF1-88EC-4AA1E083F8CA

P356

Q35345951-298895E8-2E92-463C-B2CA-9CD8A5552F62

P407

Q35345951-FA13612F-A97C-4FEA-811C-4E0BF28DE165

P433

Q35345951-BF63156B-2770-4DB8-A39D-2622B5A863D4

P478

Q35345951-4EC57B1A-160F-4BCD-A7A6-731B6E62059C

P50

Q35345951-03786628-9532-49AD-9A12-F148138352CF

Q35345951-256EF870-7FFD-44C3-ACDD-FEE48605F201

Q35345951-86608984-FDB3-444A-9050-6C90CD379C18

Q35345951-BC4A5246-B096-49CC-AC03-47BFA6C9E009

P577

Q35345951-B23794DD-2C7B-44F4-9103-F8C2A65D6A16

P5875

Q35345951-3611375E-C110-4C82-AD19-60210AE542CA

P698

Q35345951-D03DF432-D9A6-4D79-91C9-EEEA5356657A

P921

Q35345951-D315B143-8731-40F1-960A-E24B27F86363

P932

Q35345951-CF44D779-C1B9-4BBF-AA05-FA65867DB342

P356

PNAS.1111020108

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Antimicrobial resistance to ce ...... in Burkholderia pseudomallei.

@en

P2093

Aunchalee Thanwisai

http://www.w3.org/2001/XMLSchema#string

Bernice Sim

http://www.w3.org/2001/XMLSchema#string

Drew A Rholl

http://www.w3.org/2001/XMLSchema#string

Herbert P Schweizer

http://www.w3.org/2001/XMLSchema#string

Hui Hoon Chua

http://www.w3.org/2001/XMLSchema#string

Matthew T G Holden

http://www.w3.org/2001/XMLSchema#string

Narisara Chantratita

http://www.w3.org/2001/XMLSchema#string

Patrick Tan

http://www.w3.org/2001/XMLSchema#string

Premjit Amornchai

http://www.w3.org/2001/XMLSchema#string

Wen Fong Ooi

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular basis of rare aminoglycoside susceptibility and pathogenesis of Burkholderia pseudomallei clinical isolates from Thailand

Extended-spectrum beta-lactamases: a clinical update

Recurrent melioidosis in patients in northeast Thailand is frequently due to reinfection rather than relapse

Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei

Multilocus sequence typing and evolutionary relationships among the causative agents of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei

An improved screening technique for isolation of Pseudomonas pseudomallei from clinical specimens

Management of melioidosis

Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei

Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis.

Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and API 20NE.

P304

17165-17170

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1111020108

http://www.w3.org/2001/XMLSchema#string

P407

P433

41

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas P J Day

Vanaporn Wuthiekanun

Direk Limmathurotsakul

P577

2011-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51691243

http://www.w3.org/2001/XMLSchema#string

P698

21969582

http://www.w3.org/2001/XMLSchema#string

P921

Burkholderia pseudomallei

P932

3193241

http://www.w3.org/2001/XMLSchema#string